Lite Strategy LITS
NASDAQ LITS
$0.99 +0.05 (+4.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Change in Acquisitions & Divestments (2014 - 2024)

Lite Strategy (LITS) posted quarterly Change in Acquisitions & Divestments of $20.0 million for Q4 2024, down 41.77% year-over-year from $34.3 million in Q1 2024, and up 35.85% quarter-over-quarter from $14.7 million in Q3 2024.

Lite Strategy (LITS) Change in Acquisitions & Divestments (2014 - 2024) Analysis & Trends

Lite Strategy's Change in Acquisitions & Divestments history runs 11 years deep, the most recent figure standing at $20.0 million for Q4 2024.

  • In Q4 2024, Change in Acquisitions & Divestments fell 41.77% year-over-year to $20.0 million; the TTM figure through Sep 2025 stood at $20.0 million (down 78.52% YoY), while the FY2025 annual figure was $34.6 million, down 67.74% from the prior year.
  • Change in Acquisitions & Divestments for Q4 2024 stood at $20.0 million, up from $14.7 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $155.1 million in Q4 2020, with the low at $14.7 million in Q3 2024.
  • The 5-year median for Change in Acquisitions & Divestments is $39.3 million (2022), against an average of $53.4 million.
  • The sharpest annual moves came in 2020 and 2023: Change in Acquisitions & Divestments jumped 940.3% in 2020, then tumbled 61.15% in 2023.
  • Lite Strategy's Change in Acquisitions & Divestments stood at $155.1 million in 2020, then tumbled by 54.87% to $70.0 million in 2021, then plunged by 36.75% to $44.3 million in 2022, then decreased by 22.6% to $34.3 million in 2023, then plunged by 41.77% to $20.0 million in 2024.
  • Business Quant data shows LITS's Change in Acquisitions & Divestments at $20.0 million in Q4 2024, $14.7 million in Q3 2024, and $19.5 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Lite Strategy 35.71 Mn 28.17 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 19.95 Mn
Dec 31, 2024 19.95 Mn
Sep 30, 2024 14.69 Mn
Sep 30, 2024 14.69 Mn
Jun 30, 2024 19.54 Mn
Jun 30, 2024 19.54 Mn
Mar 31, 2024 24.42 Mn
Mar 31, 2024 24.42 Mn
Dec 31, 2023 34.27 Mn
Dec 31, 2023 34.27 Mn
Sep 30, 2023 29.15 Mn
Sep 30, 2023 29.15 Mn
Jun 30, 2023 29.10 Mn
Jun 30, 2023 29.10 Mn
Mar 31, 2023 34.27 Mn
Mar 31, 2023 34.27 Mn
Dec 31, 2022 44.27 Mn
Dec 31, 2022 44.27 Mn
Sep 30, 2022 47.85 Mn
Sep 30, 2022 47.85 Mn